EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural Mechanism of an Efficacy Photoswitch Targeting the β 2 ‐adrenergic Receptor

Robin Stipp, Quentin Bertrand, Matilde Trabuco, Anna Duran-Corbera, Maria Tindara Ignazzitto, Hannah Glover, Fabienne Stierli, Juanlo Catena, Melissa Carrillo, Sina Hartmann, Hans-Peter Seidel, Matthias Mulder und 18 weitere

Angewandte Chemie International Edition · 27.04.2026 · 65 (18)

DOI: 10.1002/anie.202517995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 18.03.2026. Verfasst von Robin Stipp und 29 weiteren Autor:innen. Beteiligte Einrichtung: PSI Center for Life Sciences, Paul Scherrer Institute, Villigen, Switzerland. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta-2, Azo Compounds, Adrenergic beta-2 Receptor Antagonists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Swiss National Science Foundation Project, Swiss Innovation Agency Innosuisse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The field of photopharmacology develops light‐responsive drugs that can modulate protein activity, enabling precise and dynamic investigations of their roles in health and disease. Adrenergic receptors are prominent targets for this approach because they are prototypical G protein‐coupled receptors with high clinical relevance in bronchial and cardiovascular diseases. Here, we employed the azobenzene‐based compound photoazolol‐1 in combination with time‐resolved serial crystallography at X‐ray free‐electron lasers to resolve the molecular mechanisms by which photoswitchable β‐blockers modulate activity of the β 2 ‐adrenoceptor (β 2 AR). Time‐resolved structures of the receptor bound to trans ‐photoazolol‐1 (pre‐photoconversion), a strained intermediate in the nanosecond range, and the fully photoisomerized cis ‐photoazolol‐1 reveal how isomerization of the azobenzene moiety induces distinct conformational changes within the orthosteric ligand binding pocket. Within seconds, light‐excited photoazolol‐1 adopts a new binding pose, altering interactions with extracellular loop 2 and shifting the positions of transmembrane helices 5, 6, and 7. Functional assays of β 2 AR in cellular membranes show that photoazolol‐1 acts as an efficacy photoswitch, changing from an inverse agonist to a neutral antagonist upon isomerization without leaving the binding pocket. In combination, these findings suggest a molecular mechanism for activity modulation via efficacy photoswitches and provide a framework for designing ligands that exploit light‐driven transitions within the binding pocket to achieve spatiotemporal control of receptor function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Adrenergic, beta-2Azo CompoundsAdrenergic beta-2 Receptor AntagonistsHumansCrystallography, X-RayLight

Stichwörter der Autor:innen

G protein‐coupled receptorsactivity modulationazobenzene photoswitchesphotopharmacologytime‐resolved serial femtosecond crystallography

Substanzen

Receptors, Adrenergic, beta-2azobenzeneAzo CompoundsAdrenergic beta-2 Receptor Antagonists

Autor:innen und Institutionen

  • PSI Center for Life Sciences, Paul Scherrer Institute, Villigen, Switzerland.
  • LeadXpro AG, Villigen, Switzerland.
  • MCS, Laboratory of Medicinal Chemistry, Institute For Advanced Chemistry of Catalonia (IQAC), CSIC, Barcelona, Spain.
  • Synthesis of High Added Value Molecules (SIMChem), Institut De Química Avançada De Catalunya (IQAC-CSIC), Barcelona, Spain.
  • Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
  • PSI Center for Photon Science, Paul Scherrer Institute, Villigen, Switzerland.

ORCID-Profile: Joerg Standfuss

Förderung

  • NIH HHS
  • Swiss National Science Foundation Project
  • Swiss Innovation Agency Innosuisse
  • Swiss National Science Foundation Sinergia
  • Swiss Nanoscience Institute
  • Ministerio de Ciencia e Innovación and Agencia Estatal de Investigación and ERDF-A way of making Europe
  • Ministerio de Ciencia, Innovación y Universidades
  • Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya, 2021

Zitieren

APA

Stipp, R., Bertrand, Q., Trabuco, M., Duran-Corbera, A., Ignazzitto, M. T., Glover, H., Stierli, F., Catena, J., Carrillo, M., Hartmann, S., Seidel, H. P., Mulder, M., Mason, T., Kondo, Y., Wranik, M., Appleby, M., Sager, C., Sierra, R., Gate, G., …, & Standfuss, J. (2026). Structural Mechanism of an Efficacy Photoswitch Targeting the β 2 ‐adrenergic Receptor. Angewandte Chemie International Edition, 65(18). https://doi.org/10.1002/anie.202517995

Vancouver

Stipp R, Bertrand Q, Trabuco M, Duran-Corbera A, Ignazzitto MT, Glover H, et al. Structural Mechanism of an Efficacy Photoswitch Targeting the β 2 ‐adrenergic Receptor. Angewandte Chemie International Edition. 2026;65(18). doi:10.1002/anie.202517995

BibTeX
@article{Stipp2026,
  author = {Stipp, Robin and Bertrand, Quentin and Trabuco, Matilde and Duran-Corbera, Anna and Ignazzitto, Maria Tindara and Glover, Hannah and Stierli, Fabienne and Catena, Juanlo and Carrillo, Melissa and Hartmann, Sina and Seidel, Hans-Peter and Mulder, Matthias and Mason, Thomas and Kondo, Yasushi and Wranik, Maximillian and Appleby, Martin and Sager, Christoph and Sierra, Raymond and Gate, Gregory and Schleissner, Pamela and Cheng, Xinxin and Weinert, Tobias and Cheng, Robert and Mous, Sandra and Beale, John H and Kepa, Michal and Llebaria, Amadeu and Hennig, Michael and Rovira, Xavier and Standfuss, Joerg},
  title = {Structural Mechanism of an Efficacy Photoswitch Targeting the β 2 ‐adrenergic Receptor},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  volume = {65},
  number = {18},
  doi = {10.1002/anie.202517995}
}
Kostenlos starten →